Corrigendum to <‘Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials’>[J Microbiol Immunol Infect 55 (1) (2022) 26–35, (S168411822030253X), (10.1016/j.jmii.2020.11.001)]

Shao Huan Lan, Chih Cheng Lai, Shen Peng Chang, Chun Chun Hsu, Cheng Hsin Chen, Ya Hui Wang, Yueh Lan Huang, Cheng Yi Wang, You Shuei Lin

Research output: Contribution to journalComment/debatepeer-review


Fig. 3[Formula presented] [Table presented] The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Pages (from-to)207-208
Number of pages2
JournalJournal of Microbiology, Immunology and Infection
Issue number1
Publication statusAccepted/In press - 2023

ASJC Scopus subject areas

  • Immunology and Allergy
  • General Immunology and Microbiology
  • Microbiology (medical)
  • Infectious Diseases

Cite this